JP Morgan Chase
HLTH

JP Morgan Chase’s Nobilis Health Corp. HLTH Stock Holding History

JP Morgan Chase’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,117
Closed – – 6122
2019
Q2 		$0 Hold
1,117
– – ﹤0.01% 6157
2019
Q1 		$0 Hold
1,117
– – ﹤0.01% 6202
2018
Q4 		$0 Hold
1,117
– – ﹤0.01% 6075
2018
Q3 		$1K Hold
1,117
– – ﹤0.01% 5653
2018
Q2 		$1K Hold
1,117
– – ﹤0.01% 5513
2018
Q1 		$2K Hold
1,117
– – ﹤0.01% 5303
2017
Q4 		$2K Hold
1,117
– – ﹤0.01% 5379
2017
Q3 		$2K Hold
1,117
– – ﹤0.01% 4890
2017
Q2 		$2K Sell
1,117
-35,602
-97% -$53.9K ﹤0.01% 4865
2017
Q1 		$62K Sell
36,719
-46,597
-56% -$96.9K ﹤0.01% 4472
2016
Q4 		$175K Buy
+83,316
New +$227K ﹤0.01% 4226
2016
Q3 		– Sell
-129
Closed – – 4961
2016
Q2 		$0 Buy
+129
New +$418 ﹤0.01% 5090

Other funds holding HLTH

PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

JP Morgan Chase's HLTH Position: Q3 2019 in Review

JP Morgan Chase sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 1,117 shares.

JP Morgan Chase first reported a position in HLTH in Q2 2016 and held it in 12 quarters. The position peaked at $175K in Q4 2016. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.

  • JP Morgan Chase reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
  • JP Morgan Chase sold 1,117 Nobilis Health Corp. shares in Q3 2019.
  • JP Morgan Chase first reported a position in Nobilis Health Corp. in Q2 2016 and held it in 12 quarters.
  • JP Morgan Chase's Nobilis Health Corp. position peaked at $175K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.

Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.